|Name/Company||Approval Dates and Comments|
Johnson & Johnson/ Basilea Pharmaceuticals
The US FDA rejected the New Drug Application for this antibiotic
The Therapeutic Products Directorate of Health Canada received, in September
Merck & Co.
The US FDA approved additional indications for this HPV vaccine in September
|The Danish Medicines Agency (DKMA) approved this once-daily oral treatment|
in September 2008 for the treatment of adults with severe chronic hand eczema
that is unresponsive to potent topical corticosteroids. Marketing applications
for this product are also under review in Canada and Switzerland.
|The US FDA approved the use of this 300mg once daily product in October|
2008 to be boosted with ritonavir 100mg once daily as part of a combination
therapy in treatment naïve HIV-1 infected adult patients.
In October 2008, Genentech issued a Dear Healthcare Provider letter to inform
The US FDA notified healthcare professionals in November 2008 that it is investigating